 |
|
|
| |
POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/ PD) MODELS OF JNJ-64794964, A TOLL-LIKE RECEPTOR (TLR)-7 AGONIST, IN HEALTHY ADULT SUBJECTS
|
| |
| |
AASLD 2020 Nov 11-16
Reported by Jules Levin
Liviawati Wu1, Junqi Niu2, Edward J. Gane3, Leen Slaets4, An De Creus4, Yanhua Ding2, Christian Schwabe5, Nele Goeyvaerts4, Zhongnan Xu6, Dandan Huo6, Pieter Van Remoortere7, Ullrich Schwertschlag1 and Joris J. Vandenbossche4, (1)Janssen Research and Development, South San Francisco, CA, USA, (2)The First Hospital of Jilin University, Changchun, Jilin, China, (3)New Zealand Liver Transplant Unit, Auckland City Hospital and University of Auckland, Auckland, New Zealand, (4)Janssen Research and Development, Beerse, Belgium, (5)Auckland Clinical Studies, Auckland, New Zealand, (6) Chia Tai-Tianqing Pharmaceutical Group Co., Ltd, Nanjing, Jiangsu, China, (7)Janssen Research and Development, Titusville, NJ, USA
|
| |
|
|
|
|
|
